VALOR, an adaptive design, pivotal phase III trial of vosaroxin or placebo in combination with cytarabine in first relapsed or refractory acute myeloid leukemia

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ravandi, F; Ritchie, EK; Sayar, H; Strickland, SA; Craig, M; Selleslag, DLD; Maertens, J; Havelange, V; Lancet, JE; Ketchum, SB; Acton, G; Mehta, CR; Silva, E; Craig, A; Fox, JA; Stuart, RK; Erba, HP; Vey, N; Schiller, GJ; Feldman, EJ

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012